161 related articles for article (PubMed ID: 35103261)
21. Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct.
Kim S; Jeong YK; Cho CS; Lee S; Sohn CH; Kim JH; Jeong Y; Jo DH; Bae S; Lee H
Adv Healthc Mater; 2023 Feb; 12(4):e2201825. PubMed ID: 36326169
[TBL] [Abstract][Full Text] [Related]
22. Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing.
Chae SY; Jeong E; Kang S; Yim Y; Kim JS; Min DH
J Control Release; 2022 May; 345():108-119. PubMed ID: 35247491
[TBL] [Abstract][Full Text] [Related]
23. Editing the immune system in vivo in mice using CRISPR/Cas9 ribonucleoprotein (RNP)-mediated gene editing of transplanted hematopoietic stem cells.
Wang R; Graham S; Gao L; Tam J; Levesque MC
Methods; 2021 Oct; 194():30-36. PubMed ID: 33422676
[TBL] [Abstract][Full Text] [Related]
24. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
26. Cytosolic delivery of CRISPR/Cas9 ribonucleoproteins for genome editing using chitosan-coated red fluorescent protein.
Qiao J; Sun W; Lin S; Jin R; Ma L; Liu Y
Chem Commun (Camb); 2019 Apr; 55(32):4707-4710. PubMed ID: 30942216
[TBL] [Abstract][Full Text] [Related]
27. CRISPR based targeted genome editing of Chlamydomonas reinhardtii using programmed Cas9-gRNA ribonucleoprotein.
Dhokane D; Bhadra B; Dasgupta S
Mol Biol Rep; 2020 Nov; 47(11):8747-8755. PubMed ID: 33074412
[TBL] [Abstract][Full Text] [Related]
28. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
[TBL] [Abstract][Full Text] [Related]
29. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
30. Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes.
Liang Z; Chen K; Li T; Zhang Y; Wang Y; Zhao Q; Liu J; Zhang H; Liu C; Ran Y; Gao C
Nat Commun; 2017 Jan; 8():14261. PubMed ID: 28098143
[TBL] [Abstract][Full Text] [Related]
31. Different Methods of Delivering CRISPR/Cas9 Into Cells.
Chandrasekaran AP; Song M; Kim KS; Ramakrishna S
Prog Mol Biol Transl Sci; 2018; 159():157-176. PubMed ID: 30340786
[TBL] [Abstract][Full Text] [Related]
32. First Report on Genome Editing via Ribonucleoprotein (RNP) in
Pavese V; Moglia A; Abbà S; Milani AM; Torello Marinoni D; Corredoira E; Martínez MT; Botta R
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628572
[No Abstract] [Full Text] [Related]
33. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
34. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
Bae T; Hur JW; Kim D; Hur JK
Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
[TBL] [Abstract][Full Text] [Related]
35. An efficient DNA- and selectable-marker-free genome-editing system using zygotes in rice.
Toda E; Koiso N; Takebayashi A; Ichikawa M; Kiba T; Osakabe K; Osakabe Y; Sakakibara H; Kato N; Okamoto T
Nat Plants; 2019 Apr; 5(4):363-368. PubMed ID: 30911123
[TBL] [Abstract][Full Text] [Related]
36. Optimized Guide RNA Selection Improves
Verhagen HJMP; Kuijk C; Rutgers L; Kokke AM; van der Meulen SA; van Mierlo G; Voermans C; van den Akker E
CRISPR J; 2022 Oct; 5(5):702-716. PubMed ID: 36169633
[TBL] [Abstract][Full Text] [Related]
37. Rational designs of in vivo CRISPR-Cas delivery systems.
Xu CF; Chen GJ; Luo YL; Zhang Y; Zhao G; Lu ZD; Czarna A; Gu Z; Wang J
Adv Drug Deliv Rev; 2021 Jan; 168():3-29. PubMed ID: 31759123
[TBL] [Abstract][Full Text] [Related]
38. CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos.
Kouranova E; Forbes K; Zhao G; Warren J; Bartels A; Wu Y; Cui X
Hum Gene Ther; 2016 Jun; 27(6):464-75. PubMed ID: 27094534
[TBL] [Abstract][Full Text] [Related]
39. The sonication-assisted whisker method enables CRISPR-Cas9 ribonucleoprotein delivery to induce genome editing in rice.
Nakamura A; Yano T; Mitsuda N; Furubayashi M; Ito S; Sugano SS; Terakawa T
Sci Rep; 2023 Sep; 13(1):14205. PubMed ID: 37679413
[TBL] [Abstract][Full Text] [Related]
40. Genome Editing in Ferret Airway Epithelia Mediated by CRISPR/Nucleases Delivered with Amphiphilic Shuttle Peptides.
Luo M; Ma J; Cheng X; Wu S; Bartels DJ; Guay D; Engelhardt JF; Liu X
Hum Gene Ther; 2023 Aug; 34(15-16):705-718. PubMed ID: 37335046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
